Nature Communications (Mar 2021)

Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaques

  • Pragya D. Yadav,
  • Raches Ella,
  • Sanjay Kumar,
  • Dilip R. Patil,
  • Sreelekshmy Mohandas,
  • Anita M. Shete,
  • Krishna M. Vadrevu,
  • Gaurav Bhati,
  • Gajanan Sapkal,
  • Himanshu Kaushal,
  • Savita Patil,
  • Rajlaxmi Jain,
  • Gururaj Deshpande,
  • Nivedita Gupta,
  • Kshitij Agarwal,
  • Mangesh Gokhale,
  • Basavaraj Mathapati,
  • Siddhanath Metkari,
  • Chandrashekhar Mote,
  • Dimpal Nyayanit,
  • Deepak Y. Patil,
  • B. S. Sai Prasad,
  • Annasaheb Suryawanshi,
  • Manoj Kadam,
  • Abhimanyu Kumar,
  • Sachin Daigude,
  • Sanjay Gopale,
  • Triparna Majumdar,
  • Deepak Mali,
  • Prasad Sarkale,
  • Shreekant Baradkar,
  • Pranita Gawande,
  • Yash Joshi,
  • Sidharam Fulari,
  • Hitesh Dighe,
  • Sharda Sharma,
  • Rashmi Gunjikar,
  • Abhinendra Kumar,
  • Kaumudi Kalele,
  • Vellimedu K. Srinivas,
  • Raman R. Gangakhedkar,
  • Krishna M. Ella,
  • Priya Abraham,
  • Samiran Panda,
  • Balram Bhargava

DOI
https://doi.org/10.1038/s41467-021-21639-w
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 11

Abstract

Read online

SARS-CoV-2 vaccines are needed to fight the pandemic. Here, authors show protective efficacy and immunogenicity of the inactivated SARS-CoV-2 vaccine BBV152 in rhesus macaques. This vaccine is currently in clinical development.